“Healthy Skepticism” A New Ad Campaign from Lilly Against Compounded Drugs

Related Information

Lilly launched a new ad campaign, “Healthy Skepticism” against counterfeit and compounded drugs.

What does Lilly say about counterfeit and compound drugs?

Fake or counterfeit products are produced and marketed in ways that misrepresent their efficacy, provenance, or authenticity. Counterfeit (fake or falsified) medicines may be harmful to your health because while being passed off as authentic, may contain the wrong ingredients, contain too much, too little or no active ingredient at all or contain other harmful ingredients. Statement defined by U.S. FDA. Compounded drugs are those in which process of combining, mixing, or altering ingredients to create a medication tailored to the needs of an individual patient.

Also Read: Based on Results From the Phase 3 BRUIN CLL-321 trial, Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union

Context of Ad Campaign

Two blockbuster weight loss drugs including Lilly’s Zepbound were in U.S. FDA’s drugs shortage list. During this period federal regulation allowed the sale of compound drugs to meet the requirement. However, Zepbound was removed from the U.S. FDA shortage list.


Source: Eli Lilly and CompanySafety

Advertisement

Last Modified:

Related Leads